Effectiveness of bortezomib in the treatment of thrombotic thrombocytopenic purpura: Case report

2019 ◽  
Vol 152 (6) ◽  
pp. 244-245
Author(s):  
Eva Hernández Lorente ◽  
Rafael Lluch García ◽  
Emilio Monteagudo Santolaya
2021 ◽  
pp. 1-5
Author(s):  
Maya Kornowski Cohen ◽  
Liron Sheena ◽  
Yair Shafir ◽  
Vered Yahalom ◽  
Anat Gafter-Gvili ◽  
...  

SARS-CoV-2 has been reported as a possible triggering factor for the development of several autoimmune diseases and inflammatory dysregulation. Here, we present a case report of a woman with a history of systemic lupus erythematosus and antiphospholipid syndrome, presenting with concurrent COVID-19 infection and immune thrombotic thrombocytopenic purpura (TTP). The patient was treated with plasma exchange, steroids, and caplacizumab with initial good response to therapy. The course of both TTP and COVID-19 disease was mild. However, after ADAMTS-13 activity was normalized, the patient experienced an early unexpected TTP relapse manifested by intravascular hemolysis with stable platelet counts requiring further treatment. Only 3 cases of COVID-19 associated TTP were reported in the literature thus far. We summarize the literature and suggest that COVID-19 could act as a trigger for TTP, with good outcomes if recognized and treated early.


Author(s):  
Maria Luiza Almeida Bastos ◽  
Ruth Maria Oliveira de Araújo ◽  
Deivide de Sousa Oliveira ◽  
Ana Nery Melo Cavalcante ◽  
Geraldo Bezerra da Silva Junior

2019 ◽  
Vol 175 ◽  
pp. S10
Author(s):  
K. Skarmoutsou-Tsimirika ◽  
A. Dimosiari ◽  
K. Dinas ◽  
E. Mareti ◽  
M. Sidiropoulou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document